Cite
HARVARD Citation
Li, M. et al. (2019). Design of a MUC1-based tricomponent vaccine adjuvanted with FSL-1 for cancer immunotherapy. MedChemComm. 10 (12), pp. 2073-2077. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Li, M. et al. (2019). Design of a MUC1-based tricomponent vaccine adjuvanted with FSL-1 for cancer immunotherapy. MedChemComm. 10 (12), pp. 2073-2077. [Online].